CVE-2023-38952
Last modified
CVE-2023-38952 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.. EPSS estimates a 2.44% chance of exploitation in the next 30 days.
Description
Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Zkteco | Biotime | 8.5.5 |
References
- http://zkteco.comProduct
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38952Third Party Advisory
- http://zkteco.comProduct
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38952Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-38952?
How severe is CVE-2023-38952?
How do I fix CVE-2023-38952?
Are you affected by CVE-2023-38952?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
